Adenomyosis can be relieved through the use of injections of gonadotropin-releasing hormone, but adenomyosis is not completely cured by injections. The injections used in the treatment of adenomyosis are usually gonadotropin-releasing hormone, which usually needs to be injected subcutaneously every 28 days. The treatment is more effective during the period of medication, but after stopping the medication, adenomyosis may recur quickly. Therefore, through the use of injections, only the symptoms of adenomyosis can be relieved, and it does not completely cure adenomyosis. The use of gonadotropin-releasing hormone may lead to allergic reactions to the drug, impaired glucosuria, mood changes, abnormal sensations, excessive sweating, skin rashes, bone pain and other adverse reactions, care should be taken to use the drug under the guidance of a doctor, and regular review should be taken to ensure that the product should be contraindicated for those who are allergic to the components of the product, and should be contraindicated in the period of pregnancy and breastfeeding. Patients with uterine glandular disease have different physical conditions, age and fertility requirements, and the treatment methods are different at different stages of the disease, and patients with uterine adenomyosis should undergo standardized treatment under the guidance of a doctor.